BioScience Health Innovations, Inc. (BHIC)
About BioScience Health Innovations, Inc.
BIOSCIENCE HEALTH INNOV
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $5.7M
- Net income
- $642.1K
- Total assets
- $1.7M
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
BioScience Health Innovations, Inc. (BHIC) Stock Price
- Profitable — net income of $642.1K in FY2025.
- Trading 37% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review BioScience Health Innovations, Inc..
Write a review
News about BioScience Health Innovations, Inc.
News & sentiment via Polygon.io
BioScience Health Innovations, Inc.: frequently asked questions
Is BioScience Health Innovations, Inc. an American company?
BioScience Health Innovations, Inc. is a US-based company headquartered in Salt Lake City, Utah, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is BioScience Health Innovations, Inc. headquartered?
BioScience Health Innovations, Inc. is headquartered in Salt Lake City, Utah, United States.
Is BioScience Health Innovations, Inc. publicly traded?
Yes — BioScience Health Innovations, Inc. is a publicly traded company. Its stock trades under the ticker symbol BHIC on the OTC.
What does BioScience Health Innovations, Inc. do?
BioScience Health Innovations, Inc. is an American Software company in the Technology & Electronics sector.